MBrace Therapeutics
San Diego, CA, United States · mbracetrx.com
MBrace Therapeutics is a clinical-stage company developing antibody-drug conjugates for cancer. It works on novel target discovery and ADC programs, including MBRC-101 and MBRC-201, for cancer patients. The company is based in San Diego, California, with a research laboratory in North Brunswick, New Jersey.
They take quote requests by email.
What they offer
SPARTA antibody selection technology
Uses in vivo screening to identify antibodies and drug targets for use in ADC development.
Novel antibody-target pair discovery
Identifies antibody and drug target pairs to advance targeted immunotherapies.
Antibody development against intracellular targets
Develops antibodies against intracellular proteins that translocate to the surface of cancer cells.
What they work on
- Modalities
- Small molecule, Antibody, ADC, Peptide, mRNA, Cell therapy
- Assays and studies
- in vivo screening, antibody selection
- Therapeutic areas
- oncology, cancer
- Sites
- San Diego, USA · North Brunswick, USA
- Address
- 4660 La Jolla Village Dr., Suite 895, San Diego, CA 92122
- Founded
- 2022
Similar labs. Probiocdmo, Sparx BIO, Aurigene Pharmaceutical Services, 3C Therapeutics
Found in a contract services directory. Listing built from mbracetrx.com. Work here? Claim this listing.